Abbott India - Public Comps and Valuation Multiples

Abbott India Overview

About Abbott India

Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.

Founded

1944

HQ

Employees

3.7K+

Website

abbott.co.in

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
Medical Devices
Nutraceuticals & Cosmeceuticals
BioTech
DeepTech
HealthTech
FemTech

Financials

LTM Revenue $765M

LTM EBITDA $206M

EV

$6.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Abbott India Financials

As of September 2025, Abbott India reported last 12-month revenue of $765M and EBITDA of $206M.

In the same period, Abbott India generated $344M in LTM gross profit and $171M in net income.

See Abbott India valuation multiples based on analyst estimates

Abbott India P&L

In the most recent fiscal year, Abbott India reported revenue of $728M and EBITDA of $224M.

Abbott India expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Abbott India valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$765M	XXX	$728M	XXX	XXX	XXX
Gross Profit	$344M	XXX	$329M	XXX	XXX	XXX
Gross Margin	45%	XXX	45%	XXX	XXX	XXX
EBITDA	$206M	XXX	$224M	XXX	XXX	XXX
EBITDA Margin	27%	XXX	31%	XXX	XXX	XXX
EBIT	$206M	XXX	$187M	XXX	XXX	XXX
EBIT Margin	27%	XXX	26%	XXX	XXX	XXX
Net Profit	$171M	XXX	$161M	XXX	XXX	XXX
Net Margin	22%	XXX	22%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Abbott India including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $765M. EBITDA for the last twelve months was $206M. In the most recent fiscal year, Abbott India achieved $728M in revenue and $224M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$765M	Analyst estimates available to subscribers	$728M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$344M	Analyst estimates available to subscribers	$329M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	45.0% gross margin	Analyst estimates available to subscribers	45.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$206M	Analyst estimates available to subscribers	$224M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	26.9% EBITDA margin	Analyst estimates available to subscribers	30.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$206M	Analyst estimates available to subscribers	$187M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	26.9% EBIT margin	Analyst estimates available to subscribers	25.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$171M	Analyst estimates available to subscribers	$161M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	22.3% net profit margin	Analyst estimates available to subscribers	22.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Abbott India

This financial data table provides comprehensive performance metrics for Abbott India, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Abbott India generated $765M in revenue over the last twelve months.
The company achieved $206M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $344M.
Net income over the last twelve months reached $171M.

Fiscal Year Performance

In the most recent fiscal year, Abbott India reported $728M in total revenue.
Fiscal year EBITDA was $224M.
The company maintained a gross profit margin of 45.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 30.8%.
Net profit margin reached 22.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Abbott India. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Abbott India Stock Performance

Abbott India has current market cap of INR 633B (or $7.2B), and EV of INR 604B (or $6.9B).

Market Cap Evolution

Abbott India Stock Data

As of October 29, 2025, Abbott India's stock price is INR 29798 (or $339).

See Abbott India trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$6.9B	$7.2B	XXX	XXX	XXX	XXX	$8.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Abbott India Valuation Multiples

Abbott India's trades at 9.6x EV/Revenue multiple, and 31.7x EV/EBITDA.

See valuation multiples for Abbott India and 15K+ public comps

Abbott India Financial Valuation Multiples

As of October 29, 2025, Abbott India has market cap of $7.2B and EV of $6.9B.

Equity research analysts estimate Abbott India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Abbott India has a P/E ratio of 42.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$7.2B	XXX	$7.2B	XXX	XXX	XXX
EV (current)	$6.9B	XXX	$6.9B	XXX	XXX	XXX
EV/Revenue	9.0x	XXX	9.6x	XXX	XXX	XXX
EV/EBITDA	33.4x	XXX	31.7x	XXX	XXX	XXX
EV/EBIT	33.3x	XXX	38.1x	XXX	XXX	XXX
EV/Gross Profit	19.9x	XXX	n/a	XXX	XXX	XXX
P/E	42.1x	XXX	46.5x	XXX	XXX	XXX
EV/FCF	70.6x	XXX	59.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Abbott India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Abbott India Margins & Growth Rates

Abbott India's last 12 month revenue growth is 9%

Abbott India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $39K for the same period.

Abbott India's rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Abbott India's rule of X is 49% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Abbott India and other 15K+ public comps

Abbott India Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	9%	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	5%	XXX	XXX	XXX
Rule of 40	39%	XXX	39%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	49%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$39K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	3%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	20%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial